Virology Journal

目的与范围《病毒学杂志》是一本开放的、同行评议的杂志，它研究了病毒学的各个方面，包括对动物、植物和微生物病毒的研究。该杂志欢迎对新型诊断工具、疫苗和抗病毒治疗的基础研究以及临床前和临床研究。《病毒学杂志》的编辑政策是公布所有由同行评审员评估的研究，使其成为科学文献的一个连贯、合理的补充，并减少对兴趣水平或感知影响的重视。《病毒学杂志》将刊登有关人类、动物、植物、昆虫、细菌和真菌病毒的文章。该杂志还将发表关于疫苗和抗病毒药物对病毒感染的控制和预防的分子方面的文章，以及关于病毒作为基因治疗载体的使用的文章，以及对其他药物（如朊病毒）的研究。所使用的方法和技术有望涵盖许多学科，包括分子遗传学、分子生物学、生物化学、生物物理学、结构生物学、细胞生物学、免疫学、形态学、遗传学和发病机制。病毒序列政策《病毒学杂志》欢迎提交来自新病毒的实质性序列、与人类、动物或植物的重要暴发有关的实质性序列，或含有重要多态性的序列，例如影响耐药性或受体结合变化的临床相关突变，或那些通知我们指出病毒复制或疾病的基本方面，以及下一代测序数据，如病毒体。然而，该杂志通常不会考虑与以前看到的序列相同或高度相关的短序列或序列，也不会考虑只通过地理位置的定义（例如，某一区域特定菌株的第一次描述）发布新的序列，除非有一个明确的公共卫生含义的发现。这样的增量报告可以提交给我们的姐妹期刊，遗传。物品处理费开放访问发布并非没有成本。因此，《病毒学杂志》对接受出版的每一篇文章征收1370英镑/2145美元/1745欧元的文章处理费。如果提交作者的机构是会员机构，则物品处理费用由会员机构承担，无需再支付费用。但是，如果作者的机构是支持者成员，作者应支付折扣的文章处理费用。我们通常免除来自低收入国家的作者的费用。对于其他国家，对于资金不足的作者，可以根据具体情况给予文章处理费用豁免或折扣。作者可以在提交过程中请求豁免或折扣。有关更多详细信息，请参阅我们的文章处理费用页。开放存取病毒学杂志发表的所有文章在出版后立即免费永久在线访问，无订阅费或注册障碍。有关开放式访问的更多信息，请参见此处。作为病毒学期刊上发表文章的作者，您是您文章的版权所有者，并已根据Biomed Central许可协议，提前和永久授予任何第三方使用、复制或传播您文章的权利。对于那些美国政府雇员或出于类似原因被阻止成为版权所有者的人，Biomed Central可以容纳非标准版权线。如果需要更多信息，请联系我们。

Aims and scopeVirology Journal is an open access, peer reviewed journal that considers articles on all aspects of virology, including research on the viruses of animals, plants and microbes. The journal welcomes basic research as well as pre-clinical and clinical studies of novel diagnostic tools, vaccines and anti-viral therapies.The Editorial policy of Virology Journal is to publish all research which is assessed by peer reviewers to be a coherent and sound addition to the scientific literature, and puts less emphasis on interest levels or perceived impact.Virology Journal will feature articles on human, animal, plant, insect, bacterial, and fungal viruses. The journal will also publish articles on molecular aspects of the control and prevention of viral infections with vaccines and antiviral agents and on the use of viruses as gene therapy vectors, as well as research on other agents such as prions. The approaches and techniques used are expected to encompass many disciplines, including molecular genetics, molecular biology, biochemistry, biophysics, structural biology, cell biology, immunology, morphology, genetics and pathogenesis.Policy on viral sequencesVirology Journal welcomes the submission of substantive sequences derived from new viruses, substantive sequences associated with important outbreaks in humans, animals or plants or those that contain important polymorphisms, such as clinically relevant mutations that affect drug resistance or changes in receptor binding or those that inform us about basic aspects of virus replication or disease, as well as next generation sequencing data such as viromes. However, the journal will not normally consider short sequences or sequences which are identical or highly related to those seen previously, nor will it publish sequences that are new only by definition of geographical location (e.g. the first description of a particular strain in a certain region), unless there is a clear public health implication of this finding. Such incremental reports can be submitted to our sister journal, Hereditas.Article-processing chargesOpen access publishing is not without costs. Virology Journal therefore levies an article-processing charge of ?1370/$2145/?1745 for each article accepted for publication. If the submitting author''s institution is a Member, the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.Open accessAll articles published by Virology Journal are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.As authors of articles published in Virology Journal you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BioMed Central license agreement.For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.